During the past decade, Delaware Valley Nephrology and Hypertension Associates, PC conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 8 clinical trials were completed, i.e. on average, 266.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Delaware Valley Nephrology and Hypertension Associates, PC" #1 sponsor was "Pfizer" with 3 trials, followed by "Shire" with 2 trials sponsored, "Trevi Therapeutics" with 2 trials sponsored, "Fresenius Medical Care North America" with 1 trials sponsored and "Sandoz" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Delaware Valley Nephrology and Hypertension Associates, PC" #1 collaborator was "Hospira, now a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator and "Abbott" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Delaware Valley Nephrology and Hypertension Associates, PC" are "Chronic Kidney Disease (CKD)" (2 trials), "Pruritus" (2 trials), "Uremic Pruritus" (2 trials), "Anemia" (1 trials) and "Arteriovenous Fistula" (1 trials). Many other conditions were trialed in "Delaware Valley Nephrology and Hypertension Associates, PC" in a lesser frequency.

Most popular intervention types in "Delaware Valley Nephrology and Hypertension Associates, PC" are "Biological" (5 trials), "Drug" (5 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Epoetin Hospira" (2 trials), "Participating Site's standard practice" (2 trials), "SRM003" (2 trials), "Epoetin Hospira Arm" (1 trials) and "Epogen (Amgen)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Delaware Valley Nephrology and Hypertension Associates, PC" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Delaware Valley Nephrology and Hypertension Associates, PC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Delaware Valley Nephrology and Hypertension Associates, PC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Delaware Valley Nephrology and Hypertension Associates, PC, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".